A Comment On: “Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide”

A Comment On: “Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide” Publisher

Hasanzad M¹ ; Patrinos GP^{2, 3, 4} ; Aghaei Meybodi HR⁵ ; Nikfar S¹ ; Larijani B⁶

Show Affiliations

1. Personalized Medicine Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
2. School of Health Sciences, Department of Pharmacy, University of Patras, Patras, Greece
3. College of Medicine and Health Sciences, Department of Genetics and Genomics, United Arab Emirates University, Al-Ain, Abu Dhabi, United Arab Emirates
4. Zayed Center for Health Sciences, United Arab Emirates University, Al-Ain, Abu Dhabi, United Arab Emirates
5. Evidence Based Medicine Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
6. Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran

Source: Journal of Diabetes and Metabolic Disorders Published:2024

Abstract

[No abstract available]

Related Docs

1. Old and New Anti-Obesity Drugs, Journal of Diabetes and Metabolic Disorders (2025)

Experts (# of related papers)

Shirin Hasani-Ranjbar (1)

Style	Citing Format
MLA	Hasanzad M, et al.. "A Comment On: “Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide”." Journal of Diabetes and Metabolic Disorders, vol. 23, no. 2, 2024, pp. 2411-2414.
APA	Hasanzad M, Patrinos GP, Aghaei Meybodi HR, Nikfar S, Larijani B (2024). A Comment On: “Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide”. Journal of Diabetes and Metabolic Disorders, 23(2), 2411-2414.
Chicago	Hasanzad M, Patrinos GP, Aghaei Meybodi HR, Nikfar S, Larijani B. "A Comment On: “Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide”." Journal of Diabetes and Metabolic Disorders 23, no. 2 (2024): 2411-2414.
Harvard	Hasanzad M et al. (2024) 'A Comment On: “Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide”', Journal of Diabetes and Metabolic Disorders, 23(2), pp. 2411-2414.
Vancouver	Hasanzad M, Patrinos GP, Aghaei Meybodi HR, Nikfar S, Larijani B. A Comment On: “Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide”. Journal of Diabetes and Metabolic Disorders. 2024;23(2):2411-2414.
BibTex	@article{ author = {Hasanzad M and Patrinos GP and Aghaei Meybodi HR and Nikfar S and Larijani B}, title = {A Comment On: “Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide”}, journal = {Journal of Diabetes and Metabolic Disorders}, volume = {23}, number = {2}, pages = {2411-2414}, year = {2024} }
RIS	TY - JOUR AU - Hasanzad M AU - Patrinos GP AU - Aghaei Meybodi HR AU - Nikfar S AU - Larijani B TI - A Comment On: “Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide” JO - Journal of Diabetes and Metabolic Disorders VL - 23 IS - 2 SP - 2411 EP - 2414 PY - 2024 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract